Patient Registry of Blind Subjects With Sleep-related Problems

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
Vanda Pharmaceuticals
Study ID
NCT01195558
Status
Recruiting

Conditions

  • Sleep-wake Disorder in Blind Individuals

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Data collection on blindness and sleep problems — OTHER
    Data related to degree of vision impairment and sleep problems is collected through a phone or web survey

Study Details

Non-24-hour sleep-wake disorder (Non-24) is a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness. This is a research protocol to develop a patient registry of subjects who may suffer from Non-24 and who are blind. Subjects participate in the study through a phone survey. This registry will be used to better understand, sleep related problems in blind individuals, including the investigation of a potential treatment, recruitment for future clinical studies, and to provide a forum for raising awareness about Non-24. The survey consists of questions regarding the degree of vision impairment and sleep problems that the subjects may be experiencing.

Key Dates

Start date
Apr 30, 2010
Status verified
Jun 2020
Primary completion
Apr 30, 2030
Completion
Apr 30, 2030

Study Design

Enrollment
10,000 participants (estimated)

Arms

  • Arm: Blind with sleep problems
    Blind individuals with no light perception and with sleep-related problems who may suffer from Non-24

Primary Outcome Measure

Number of blind participants [ Time Frame: ongoing ]

Central Contacts

  • Vanda Pharmaceuticals
    (202) 734-3400

Locations (1)

FacilityCityStateZIPSite coordinators
Vanda PharmaceuticalsWashington D.C.District of Columbia20037
Vanda Pharmaceuticals
202-734-3400

Find similar trials in Washington D.C., DC